Molecular therapy for Ischemic heart disease: Expression of p63 in bone-marrow derived cells mediates cardiac repair after myocardial infarction via down regulation of its target gene, 13/February/2015, 21.53

Sorry for the inconvenience,12/02/2015
February 13, 2015
Mechanistic insight into Interleukin-mediated tumorigenesis: IL-17 increases the expression of oncogenic protein MDM2, a negative regulator of p53, via down regulation of its target gene, 13/February/2015, 22.00
February 13, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular therapy for Ischemic heart disease: Expression of p63 in bone-marrow derived cells mediates cardiac repair after myocardial infarction via down regulation of its target gene, 13/February/2015, 21.53, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that p63, by suppressing the expression of its target gene, it may promote cardiac repair after myocardial infarction.  Thus, pharmacological formulations encompassing “p63 activators  may be used to promote cardiac repair.

Amount: $ 300*

Undisclosed information: How p63 promotes cardiac repair after myocardial infarction

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.